| Apixaban |
EU/1/11/619/002 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 20 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy |
36.87 |
7.37 |
44.24 |
4% |
1.47 |
38.34 |
7.67 |
46.01 |
16% |
5.9 |
44.24 |
8.85 |
53.09 |
|
НСР-4899/22.10.2014; НСР-9829/21.07.2016 |
02.09.2016 |
02.09.2016 |
Неактивен |
3265 |
| Apixaban |
EU/1/11/619/002 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 20 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy |
36.87 |
7.37 |
44.24 |
4% |
1.47 |
38.34 |
7.67 |
46.01 |
16% |
5.9 |
44.24 |
8.85 |
53.09 |
|
НСР-4899/22.10.2014; НСР-9829/21.07.2016 |
02.09.2016 |
02.09.2016 |
Неактивен |
3265 |
| Apixaban |
EU/1/11/619/002 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 20 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy |
37.16 |
7.43 |
44.59 |
4% |
1.49 |
38.65 |
7.73 |
46.38 |
16% |
5.95 |
44.6 |
8.92 |
53.52 |
|
НСР-4899/22.10.2014 |
06.11.2014 |
06.11.2014 |
Неактивен |
3265 |
| Apixaban |
EU/1/11/619/002 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 20 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy |
37.16 |
7.43 |
44.59 |
4% |
1.49 |
38.65 |
7.73 |
46.38 |
16% |
5.95 |
44.6 |
8.92 |
53.52 |
|
НСР-4899/22.10.2014 |
06.11.2014 |
06.11.2014 |
Неактивен |
3265 |
| Metoclopramide |
20160367 |
Elitan, Solution for injection, 10 mg/2 ml, mg, Pack: 100 |
Medochemie Ltd., Кипър |
Medochemie Ltd., Кипър |
97.79 |
19.56 |
117.35 |
4% |
3.91 |
101.7 |
20.34 |
122.04 |
16% |
15.65 |
117.35 |
23.47 |
140.82 |
НСР-12407/18.04.2017 и НСР-12549/28.04.2017 (предварително изпълнение) |
НСР-11549/26.01.2017 г. |
11.02.2017 |
02.05.2017 |
Активен |
15587 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/004 |
Elocta, Powder and solvent for solution for injection, 1000, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
1224.78 |
244.96 |
1469.74 |
4% |
10 |
1234.78 |
246.96 |
1481.74 |
16% |
25 |
1259.78 |
251.96 |
1511.74 |
|
НСР-12362/18.04.2017; НСР-15073/23.02.2018; КП-54/19.06.2019 и НСР-17247/14.11.2018 |
02.08.2019 |
02.08.2019 |
Активен |
15668 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/004 |
Elocta, Powder and solvent for solution for injection, 1000, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
1224.78 |
244.96 |
1469.74 |
4% |
10 |
1234.78 |
246.96 |
1481.74 |
16% |
25 |
1259.78 |
251.96 |
1511.74 |
|
НСР-12362/18.04.2017; НСР-15073/23.02.2018; КП-54/19.06.2019 и НСР-17247/14.11.2018 |
02.08.2019 |
02.08.2019 |
Неактивен |
15668 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/001 |
Elocta, Powder and solvent for solution for injection, 250, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
306.2 |
61.24 |
367.44 |
4% |
10 |
316.2 |
63.24 |
379.44 |
16% |
25 |
341.2 |
68.24 |
409.44 |
|
НСР-12362/18.04.2017; НСР-15072/23.02.2018; КП-56/19.06.2019 и НСР-17249/14.11.2018 |
02.08.2019 |
02.08.2019 |
Активен |
15666 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/001 |
Elocta, Powder and solvent for solution for injection, 250, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
306.2 |
61.24 |
367.44 |
4% |
10 |
316.2 |
63.24 |
379.44 |
16% |
25 |
341.2 |
68.24 |
409.44 |
|
НСР-12362/18.04.2017; НСР-15072/23.02.2018; КП-56/19.06.2019 и НСР-17249/14.11.2018 |
02.08.2019 |
02.08.2019 |
Неактивен |
15666 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/001 |
Elocta, Powder and solvent for solution for injection, 250, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
316.84 |
63.37 |
380.21 |
4% |
10 |
326.84 |
65.37 |
392.21 |
16% |
25 |
351.84 |
70.37 |
422.21 |
|
НСР-12362/18.04.2017; НСР-15072/23.02.2018 |
10.03.2018 |
02.04.2018 |
Неактивен |
15666 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/004 |
Elocta, Powder and solvent for solution for injection, 1000, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
1267.38 |
253.48 |
1520.86 |
4% |
10 |
1277.38 |
255.48 |
1532.86 |
16% |
25 |
1302.38 |
260.48 |
1562.86 |
|
НСР-12362/18.04.2017; НСР-15073/23.02.2018 |
10.03.2018 |
02.04.2018 |
Неактивен |
15668 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/001 |
Elocta, Powder and solvent for solution for injection, 250, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
352.05 |
70.41 |
422.46 |
4% |
10 |
362.05 |
72.41 |
434.46 |
16% |
25 |
387.05 |
77.41 |
464.46 |
|
НСР-12362/18.04.2017 |
03.05.2017 |
02.06.2017 |
Неактивен |
15666 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/004 |
Elocta, Powder and solvent for solution for injection, 1000, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
1408.2 |
281.64 |
1689.84 |
4% |
10 |
1418.2 |
283.64 |
1701.84 |
16% |
25 |
1443.2 |
288.64 |
1731.84 |
|
НСР-12362/18.04.2017 |
03.05.2017 |
02.06.2017 |
Неактивен |
15668 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/002 |
Elocta, Powder and solvent for solution for injection, 500, IU, Pack: 1 vial (powder)+ 1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
612.39 |
122.48 |
734.87 |
4% |
10 |
622.39 |
124.48 |
746.87 |
16% |
25 |
647.39 |
129.48 |
776.87 |
|
НСР-12362/18.04.2017; НСР-13653/01.09.2017; КП-55/19.06.2019 и НСР-17248/14.11.2018 |
02.08.2019 |
02.08.2019 |
Активен |
15667 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/002 |
Elocta, Powder and solvent for solution for injection, 500, IU, Pack: 1 vial (powder)+ 1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
612.39 |
122.48 |
734.87 |
4% |
10 |
622.39 |
124.48 |
746.87 |
16% |
25 |
647.39 |
129.48 |
776.87 |
|
НСР-12362/18.04.2017; НСР-13653/01.09.2017; КП-55/19.06.2019 и НСР-17248/14.11.2018 |
02.08.2019 |
02.08.2019 |
Неактивен |
15667 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/002 |
Elocta, Powder and solvent for solution for injection, 500, IU, Pack: 1 vial (powder)+ 1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
633.69 |
126.74 |
760.43 |
4% |
10 |
643.69 |
128.74 |
772.43 |
16% |
25 |
668.69 |
133.74 |
802.43 |
|
НСР-12362/18.04.2017; НСР-13653/01.09.2017 |
16.09.2017 |
02.10.2017 |
Неактивен |
15667 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/002 |
Elocta, Powder and solvent for solution for injection, 500, IU, Pack: 1 vial (powder)+ 1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
704.1 |
140.82 |
844.92 |
4% |
10 |
714.1 |
142.82 |
856.92 |
16% |
25 |
739.1 |
147.82 |
886.92 |
|
НСР-12362/18.04.2017 |
02.06.2017 |
02.06.2017 |
Неактивен |
15667 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/007 |
Elocta, Powder and solvent for solution for injection, 3000, IU, Pack: 1 vial (powder) +1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
3674.36 |
734.87 |
4409.23 |
4% |
10 |
3684.36 |
736.87 |
4421.23 |
16% |
25 |
3709.36 |
741.87 |
4451.23 |
|
НСР-15271/16.03.2018 Предварително изпълнение; КП-51/19.06.2019 и НСР-17244/14.11.2018 |
02.08.2019 |
02.08.2019 |
Активен |
16051 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/007 |
Elocta, Powder and solvent for solution for injection, 3000, IU, Pack: 1 vial (powder) +1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
3674.36 |
734.87 |
4409.23 |
4% |
10 |
3684.36 |
736.87 |
4421.23 |
16% |
25 |
3709.36 |
741.87 |
4451.23 |
|
НСР-15271/16.03.2018 Предварително изпълнение; КП-51/19.06.2019 и НСР-17244/14.11.2018 |
02.08.2019 |
02.08.2019 |
Неактивен |
16051 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/006 |
Elocta, Powder and solvent for solution for injection, 2000, IU, Pack: 1 vial (powder) +1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
2449.56 |
489.91 |
2939.47 |
4% |
10 |
2459.56 |
491.91 |
2951.47 |
16% |
25 |
2484.56 |
496.91 |
2981.47 |
|
НСР-15271/16.03.2018 Предварително изпълнение; КП-52/19.06.2019 и НСР-17245/14.11.2018 |
02.08.2019 |
02.08.2019 |
Активен |
16050 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/006 |
Elocta, Powder and solvent for solution for injection, 2000, IU, Pack: 1 vial (powder) +1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
2449.56 |
489.91 |
2939.47 |
4% |
10 |
2459.56 |
491.91 |
2951.47 |
16% |
25 |
2484.56 |
496.91 |
2981.47 |
|
НСР-15271/16.03.2018 Предварително изпълнение; КП-52/19.06.2019 и НСР-17245/14.11.2018 |
02.08.2019 |
02.08.2019 |
Неактивен |
16050 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/005 |
Elocta, Powder and solvent for solution for injection, 1500, IU, Pack: 1 vial (powder) +1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
1837.17 |
367.43 |
2204.6 |
4% |
10 |
1847.17 |
369.43 |
2216.6 |
16% |
25 |
1872.17 |
374.43 |
2246.6 |
|
НСР-15271/16.03.2018 Предварително изпълнение; КП-53/19.06.2019 и НСР-17246/14.11.2018 |
02.08.2019 |
02.08.2019 |
Активен |
16049 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/005 |
Elocta, Powder and solvent for solution for injection, 1500, IU, Pack: 1 vial (powder) +1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
1837.17 |
367.43 |
2204.6 |
4% |
10 |
1847.17 |
369.43 |
2216.6 |
16% |
25 |
1872.17 |
374.43 |
2246.6 |
|
НСР-15271/16.03.2018 Предварително изпълнение; КП-53/19.06.2019 и НСР-17246/14.11.2018 |
02.08.2019 |
02.08.2019 |
Неактивен |
16049 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/005 |
Elocta, Powder and solvent for solution for injection, 1500, IU, Pack: 1 vial (powder) +1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
1901.07 |
380.21 |
2281.28 |
4% |
10 |
1911.07 |
382.21 |
2293.28 |
16% |
25 |
1936.07 |
387.21 |
2323.28 |
|
НСР-15271/16.03.2018 Предварително изпълнение |
16.03.2018 |
02.04.2018 |
Неактивен |
16049 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/007 |
Elocta, Powder and solvent for solution for injection, 3000, IU, Pack: 1 vial (powder) +1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
3802.13 |
760.43 |
4562.56 |
4% |
10 |
3812.13 |
762.43 |
4574.56 |
16% |
25 |
3837.13 |
767.43 |
4604.56 |
|
НСР-15271/16.03.2018 Предварително изпълнение |
16.03.2018 |
02.04.2018 |
Неактивен |
16051 |